Supreme Court preserves access to widely used abortion pill, while lawsuit plays out
The Supreme Court has preserved access to mifepristone, a widely used abortion pill, while a lawsuit challenging its availability proceeds. The court rejected lower-court restrictions that would have required in-person doctor visits and halted mail delivery of the drug.
Briefing Summary
AI-generatedThe Supreme Court has preserved access to mifepristone, a widely used abortion pill, while a lawsuit challenging its availability proceeds. The court rejected lower-court restrictions that would have required in-person doctor visits and halted mail delivery of the drug. This decision allows women to continue obtaining mifepristone through pharmacies or mail, with access likely uninterrupted until at least next year. The justices granted emergency requests from mifepristone makers appealing a federal appeals court ruling. Justices Clarence Thomas and Samuel Alito dissented. Anti-abortion groups are seeking FDA restrictions on the drug, while the Republican administration states the review process takes time.
Article analysis
Model · rule-basedKey claims
5 extractedThe FDA first approved mifepristone for abortion use in 2000 and stopped requiring in-person visits five years ago.
Thomas wrote that the companies are not entitled to court action to spare them 'lost profits from their criminal enterprise.'
Justices Clarence Thomas and Samuel Alito dissented.
The court's order allows continued access to mifepristone through pharmacies or mail without an in-person doctor visit.
The Supreme Court preserved women's access to mifepristone, rejecting lower-court restrictions.